Adagene Reports Full Year 2021 Financial Results and Provides Corporate Update
- 2022 clinical data readouts on track to show potential best-in-class safety profile for anti-CTLA-4 programs (ADG116, ADG126) with PD-1...
- 2022 clinical data readouts on track to show potential best-in-class safety profile for anti-CTLA-4 programs (ADG116, ADG126) with PD-1...
NEWTON, Mass., March 31, 2022 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition,...
Odyssey Group International Announces Formation of Military Advisory Board James “Jim” Linder: Major General USA (r) Former Chief of Staff...
Shockwave M5+ IVL Catheter Broadens Options for Treatment of Peripheral ArteriesSANTA CLARA, Calif., March 31, 2022 (GLOBE NEWSWIRE) -- Shockwave...
Focus on Cancer Immunotherapy and Next-Generation Vaccines and a Strong Balance Sheet Conference Call Begins Today at 11:00 a.m. Eastern...
NEW YORK and SYDNEY, Australia, March 31, 2022 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the...
Call Scheduled for Today, Thursday, March 31, 2022 at 5:00 pm ETHIGHLANDS RANCH, Colo., March 31, 2022 (GLOBE NEWSWIRE) --...
ONS-5010 / LYTENAVA™ (bevacizumab-vikg), if approved, expected to receive 12 years of marketing exclusivityISELIN, N.J., March 31, 2022 (GLOBE NEWSWIRE)...
Clinicians reviewing ultrasound scan March 31, 2022 Industry leading vendor-neutral solution for automated 2D and 3D quantification for browser-accessible echocardiography...
– First description of new, comprehensive anellovirus antibody analysis tool, AnelloScan – – Cross-sectional study supports that anelloviruses are associated with...
Entered into an exclusive global license agreement with Organon to commercialize XACIATO™ (clindamycin phosphate vaginal gel, 2%) that includes a $10...
CD388 is a drug-Fc conjugate (DFC) from Cidara’s Cloudbreak® platform and is designed to transform the standard of care for...
NORCROSS, Ga., March 31, 2022 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target...
REDWOOD CITY, Calif., March 31, 2022 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (NASDAQ: JSPR), a biotechnology company focused on hematopoietic...
Three leading experts in gynecological oncology will discuss treatment landscape and unmet needs in ovarian cancer Event on Monday, April...
SOUTH SAN FRANCISCO, Calif., March 31, 2022 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO) today announced its operating and...
Fumi Hayashida, KMHA Fumi Hayashida, President and CEO, Konica Minolta Healthcare Americas, Inc.WAYNE, N.J., March 31, 2022 (GLOBE NEWSWIRE) --...
Results Support Further Exploration of Therapeutic Potential of Lomecel-B to Slow Cognitive Decline, Improve Quality of Life for Alzheimer’s Patients...
Preliminary safety data suggests lead iNKT agonists, PORT-2 and PORT-3, are well tolerated supporting continued development Company continues to work...
WARSAW, Ind., March 31, 2022 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on...